21 / 29
Page 99
Notes:
Journal of Gastrointestinal & Digestive System | ISSN: 2161-069X | Volume: 8
&
&
October 29-30, 2018 | San Francisco, USA
International Conference on
Gastrointestinal Cancer and Therapeutics
4
th
World Congress on
Digestive & Metabolic Diseases
26
th
Annual Congress on
Cancer Science and Targeted Therapies
Log odds of positive lymph nodes stratification: What is the prognostic role in colorectal cancer patients
Andrea Scarinci
1
, Tatiana Di Cesare, Daniele Cavaniglia, Tiziano Neri, Giulia Cosenza, Michelle Colletti
2
and
Andrea Liverani
1
1
Regina Apostolorum Hospital, Italy
2
Memorial Sloan Ketering Cancer Center, USA
N
odal status is an important prognostic factor for patients with CRC without distant synchronous metastasis. The aim of the study
was to assess the prognostic value of LODDS in predicting the survival outcome of CRC in patients with radical resection. We
enrolled 323 consecutive patients with primary CRC that underwent curative resection. LODDS values were calculated by empirical
logistic formula, log(pnod + 0.5)/(tnod − pnod + 0.5). It was defined as the log of the ratio between the number of positive nodes
and the number of negative nodes. The patients were divided into three groups: LODDS0 (≤ −1.36), LODDS1 (> −1.36 ≤ −0.53) and
LODDS2 (> −0.53). The 1- and 3-year OS was 90.8 and 78.5%, respectively, for all 323 CRC patients enrolled. Age, TNM staging,
pT and pN stage, tumor grade, microvascular and perineural invasion, Lymph Node Ratio (LNR) and LODDS were all statistically
significantly correlated with overall survival. In a multivariate analysis with the Cox proportional hazard method, LODDS proved to
be an independent prognostic factor of 3-year OS, while the pN stage and lymph node ratio demonstrated no statistical significance.
ROC analyses showed that LODDS predicted OS better than LNR. The data of this study, in according to literature, showed that
LODDS tumor staging system has a superior prognostic relevance compared to pN stage and LNR, and proving to be an accurate
clinical tool to stratify and to predict survival of CRC patients.
andreascarinci82@hotmail.comJ Gastrointest Dig Syst 2018, Volume 8
DOI: 10.4172/2161-069X-C8-086